CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 65 enrolled
Drug / intervention
Sodium Fluoride (NaF) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00708305
NCT00708305Phase 3Completed

Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes

GlaxoSmithKline·interventional·Posted Jul 2, 2008·Updated Jan 1, 2015

In Brief

A Phase 3 clinical trial evaluating Sodium Fluoride (NaF) and Placebo for Dental Caries. Completed, enrolled 65 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate the efficacy of different sodium fluoride (NaF) containing toothpastes in prevention of dental caries. Change from baseline fluoride data at various time points up to four hours after a single brushing with NaF containing toothpastes will be evaluated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Caries
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 2, 2008
Enrollment StartJun 1, 2008
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 18 years ago

Interventions

Sodium Fluoride (NaF)drug

Different fluoride toothpastes containing between 1400ppmF - 1450ppmF of fluoride as NaF

Placebodrug

Fluoride free toothpaste (0ppmF)